Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy. (2016)
Attributed to:
Peptide conjugated oligonucleotides for splice switching therapy of Spinal Muscular Atrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1605731113
PubMed Identifier: 27621445
Publication URI: http://europepmc.org/abstract/MED/27621445
Type: Journal Article/Review
Volume: 113
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 39
ISSN: 0027-8424